Ikena Oncology (NASDAQ:IKNA – Get Free Report)‘s stock had its “neutral” rating reissued by research analysts at Wedbush in a research report issued on Thursday,RTT News reports. They currently have a $2.00 target price on the stock. Wedbush’s target price indicates a potential upside of 18.34% from the company’s previous close. Separately, HC Wainwright reaffirmed […]

Wedbush reissued their neutral rating on shares of GoPro (NASDAQ:GPRO – Free Report) in a research report released on Wednesday morning, RTT News reports. The firm currently has a $1.50 target price on the stock. Separately, StockNews.com upgraded GoPro from a “sell” rating to a “hold” rating in a research note on Friday, September 13th. […]